ARCHIVES

FDA Approves Votrient For Soft Tissue Sarcomas

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Barret’s Less of a Risk Factor For Cancer of the Esophagus

June 24, 2011

Intermittent Androgen Deprivation Therapy Not Equal to Continuous Treatment, Study Finds

April 26, 2013

Fondaparinux Prevents DVT In Acutely III Medical Patients

January 30, 2004

Senate Legislation Tackles Drug Shortages, Proposes Faster Approval For “Breakthroughs”

April 27, 2012

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

November 4, 1988

Georgetown-Hackensack Consortium Plan Points to Rising Value of NCI Designation

April 19, 2013